Layla Nohelia Van Doren MD

Clotting Disorder, Hemophilia & Bleeding Disorder, Sickle Cell & Other Anemias

Assistant Professor of Medicine at Yale School of Medicine

400 Parnassus AveSan Francisco, CA 94143
Phone+1 415-353-2421

Dr. Van Doren is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Van Doren's full profile Already have an account?

Summary

Dr. Van Doren received her medical degree from George Washington University School of Medicine and Health Sciences. She completed residency at University of Southern California/ Los Angeles County. She then completed Hematology & Oncology fellowship at Tufts Medical Center in Boston, where she served as chief fellow from 2017-2019. Dr. Van Doren’s clinical practice focuses on the diagnosis and management of bleeding and clotting disorders, with a special emphasis in women’s health. She has a particular interest and pregnancy related hematologic disorders, such as hemolytic disease of the fetus (HDFN) and neonatal alloimmune thrombocytopenia (NAIT). Other areas of expertise include difficult-to-manage blood disorders, including antiphospholipid antibody syndrome (APLS), heparin-induced thrombocytopenia (HIT), immune thrombocytopenic purpura (ITP), autoimmune hemolytic anemia (AIHA), and thrombotic thrombocytopenic purpura (TTP).

Education & Training

Tufts Medical CenterFellowship, Hematology and Medical Oncology, 2016 - 2019
University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Internal Medicine, 2013 - 2016
George Washington University School of Medicine and Health SciencesClass of 2013
Loma Linda UniversityMBA, Healthcare Administration, 2007 - 2009
California State University, San BernardinoBachelor of Arts, Art history; minor biology, 2002 - 2007

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

CA State Medical License 2015 - 2028
CT State Medical License 2022 - 2026
NY State Medical License 2019 - 2022
MA State Medical License 2016 - 2019
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

Center for Advanced Training in Hemophilia and Inhibitor Management Nationwide Children's Hospital, 2017
59th annual pre-ASH Trainee Workshop: Building a Career in Hemostasis and Thrombosis Hemostasis and Thrombosis Research Society, 2017

Publications & Presentations

PubMed

7 citations
Acute and chronic pain management in patients with sickle cell disease in the modern era: a comprehensive review.
Seda S Tolu, Layla Van Doren
Transfusion and Apheresis Science. 2022-10-01
1 citations
Anti-SARS-CoV-19 antibodies in children and adults with sickle cell disease: A single-site analysis in New York City.
Nancy S Green, Layla Van Doren, Maureen Licursi, Daniel D Billings, Luke A Sandoval
British Journal of Haematology. 2022-08-01
7 citations
Endovascular Management of Venous Thromboembolic Disease in the Oncologic Patient Population.
Sirish A Kishore, Raazi Bajwa, Layla Van Doren, Cy Wilkins, Gerard J O'Sullivan
Current Oncology Reports. 2022-03-01

Lectures

Blockade of Lipid Receptor GPR31 Suppresses Platelet Reactivity and Thrombosis with Minimal Effect on Hemostasis
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019

Research History

Research FellowUnder the guidance of Lidija Covic, PhD, in the Hemostasis and Thrombosis Laboratory, Dr. Van Doren established a mechanistic framework and validated the pathophysiologic and therapeutic relevance of the lipid receptor GPR31 during PAR4-depedant platelet activation.2017 - 2019